Mayne Pharma reported $-50370000 in Net Income for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Ansell ANN:AU $ 77.2M 63M
Cochlear COH:AU $ 169.3M 79M
CSL CSL:AU $ 1.76B 1.2B
Ecofibre Ltd EOF:AU -6694000 5.25M
Healius Ltd HLS:AU $ 233.2M 252.3M
Integral Diagnostics Ltd IDX:AU 10.2M 1.17M
Nanosonics Ltd NAN:AU $ 3.88M 3.24M
Next Science Ltd NXS:AU -5150580 951.52K
Polynovo Ltd PNV:AU -1067290 2.47M
Probiotec Ltd PBP:AU 4.44M 834.93K
Ramsay Health Care RHC:AU $ 158.9M 64.1M
ResMed RMD:AU $ 179.01M 22.74M
Sigma Healthcare Ltd SIG:AU -5939000 4.64M
Sonic Healthcare SHL:AU $ 827.66M 190.26M
Telix Pharmaceuticals Ltd TLX:AU -47996000 15.48M